Nureca Ltd Reports Q1 Financial Results, Shows Growth in Revenue and Profits
Nureca Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved the results, which reflect the performance across both the company and its group entities.The Company's operations fall under a single business segment: "Home healthcare and wellness products."
Standalone Financial Performance (Q1 FY2026)
The unaudited standalone financial results for Nureca Limited show strong revenue generation during the quarter. The results are presented below, with all figures in Rs. millions.| Particulars | 30 June 2026 (Unaudited) | 31 March 2026 (Refer Note 3) | 30 June 2025 (Unaudited) | 31 March 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 403.96 | 354.05 | 343.24 | 1,472.10 |
| Other income | 19.18 | 10.62 | 25.92 | 83.20 |
| Total income | 423.14 | 364.67 | 369.16 | 1,555.30 |
| Total expenses | 386.95 | 426.19 | 360.83 | 1,526.94 |
| Profit before tax for the period | 36.19 | (61.52) | 8.33 | 28.36 |
| Profit after tax for the period | 24.32 | (66.25) | 5.52 | 2.97 |
| Total comprehensive income | 24.32 | (65.74) | 5.52 | 3.48 |
Consolidated Financial Performance (Q1 FY2026)
The unaudited consolidated financial results for the quarter ended June 30, 2026, reflect total income of Rs. 421.63 million and a profit after tax of Rs. 30.67 million.| Particulars | 30 June 2026 (Unaudited) | 31 March 2026 (Refer Note 3) | 30 June 2025 (Unaudited) | 31 March 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 403.43 | 354.05 | 341.76 | 1,469.63 |
| Other income | 18.20 | 10.17 | 25.72 | 80.96 |
| Total income | 421.63 | 364.22 | 367.48 | 1,550.59 |
| Total expenses | 377.31 | 419.33 | 355.17 | 1,500.81 |
| Profit before tax for the period | 44.33 | (55.11) | 12.31 | 49.78 |
| Profit after tax for the period from continuing operations | 30.67 | (60.92) | 8.13 | 20.80 |
Operational and Strategic Details
The financial results were approved by the Board of Directors following a meeting held on July 21, 2026. The Company previously undertook a buyback of equity shares through a tender offer route during the quarter ended December 31, 2025, at a price of ₹330 per share.Furthermore, Nureca Limited had initiated a Scheme of Merger by Absorption involving Nureca Technologies Private Limited, a wholly owned subsidiary, which was set to become effective from April 1, 2025, pending regulatory approvals.
The financial statements have been reviewed by independent auditors and approved by the Audit Committee.
NURECA Stock Price Movement
Nureca Limited shares edged higher today, settling at ₹292.19 and achieving a notable 3.73% gain in after-hours trading. The equity saw active buying interest, with 40,148 shares traded throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.